Bulk Manufacturer of Controlled Substances Application: Synthcon, LLC, 13141-13143 [2018-06090]
Download as PDF
<![CDATA[
13141
Federal Register / Vol. 83, No. 59 / Tuesday, March 27, 2018 / Notices
DEPARTMENT OF THE INTERIOR
Bureau of Land Management
[LLCO956000 L14400000.BJ0000 18X]
Notice of Filing of Plats of Survey,
Colorado
Bureau of Land Management,
Interior.
ACTION: Notice of official filing.
AGENCY:
The plats of survey of the
following described lands are scheduled
to be officially filed in the Bureau of
Land Management (BLM), Colorado
State Office, Lakewood, Colorado, 30
calendar days from the date of this
publication. The surveys, which were
executed at the request of the U.S.
Forest Service and the BLM, are
necessary for the management of these
lands.
DATES: Unless there are protests of this
action, the plats described in this notice
will be filed on April 26, 2018.
ADDRESSES: You may submit written
protests to the BLM Colorado State
Office, Cadastral Survey, 2850
Youngfield Street, Lakewood, CO
80215–7093.
FOR FURTHER INFORMATION CONTACT:
Randy Bloom, Chief Cadastral Surveyor
for Colorado, (303) 239–3856; rbloom@
blm.gov. Persons who use a
telecommunications device for the deaf
may call the Federal Relay Service at 1–
800–877–8339 to contact the above
individual during normal business
hours. The Service is available 24 hours
a day, seven days a week, to leave a
message or question with the above
individual. You will receive a reply
during normal business hours.
SUPPLEMENTARY INFORMATION: The plat
and field notes of the dependent
resurvey and subdivision of section 13
in Township 1 South, Range 77 West,
Sixth Principal Meridian, Colorado,
were accepted on February 20, 2018.
SUMMARY:
The plat, in 2 sheets, and field notes
of the dependent resurvey and survey in
Township 1 South, Range 80 West,
Sixth Principal Meridian, Colorado,
were accepted on March 2, 2018.
A person or party who wishes to
protest any of the above surveys must
file a written notice of protest within 30
calendar days from the date of this
publication at the address listed in the
ADDRESSES section of this notice. A
statement of reasons for the protest may
be filed with the notice of protest and
must be filed within 30 calendar days
after the protest is filed. If a protest
against the survey is received prior to
the date of official filing, the filing will
be stayed pending consideration of the
protest. A plat will not be officially filed
until the day after all protests have been
dismissed or otherwise resolved.
Before including your address, phone
number, email address, or other
personal identifying information in your
protest, please be aware that your entire
protest, including your personal
identifying information, may be made
publicly available at any time. While
you can ask us in your comment to
withhold your personal identifying
information from public review, we
cannot guarantee that we will be able to
do so.
Authority: 43 U.S.C. Chap. 3.
Randy A. Bloom,
Chief Cadastral Surveyor.
[FR Doc. 2018–06093 Filed 3–26–18; 8:45 am]
BILLING CODE 4310–JB–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration in
accordance with 21 CFR 1301.33(a) on
or before May 29, 2018.
DATES:
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DRW, 8701
Morrissette Drive, Springfield, Virginia
22152.
ADDRESSES:
The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Deputy Assistant
Administrator of the DEA Office of
Diversion Control (‘‘Deputy Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.33(a), this is notice that on January
29, 2018, Synthcon, LLC, 770 Wooten
Road, Unit 101, Colorado Springs, CO
80915 applied to be registered as a bulk
manufacturer of the following basic
classes of controlled substances:
SUPPLEMENTARY INFORMATION:
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Application: Synthcon,
LLC
ACTION:
Notice of application.
amozie on DSK30RV082PROD with NOTICES
Controlled substance
Drug code
3-Fluoro-N-methylcathinone (3-FMC) ......................................................................................................................
Cathinone ................................................................................................................................................................
Methcathinone .........................................................................................................................................................
4-Fluoro-N-methylcathinone (4-FMC) ......................................................................................................................
Pentedrone (a-methylaminovalerophenone) ...........................................................................................................
Mephedrone (4-Methyl-N-methylcathinone) ............................................................................................................
4-Methyl-N-ethylcathinone (4-MEC) ........................................................................................................................
Naphyrone ...............................................................................................................................................................
N-Ethylamphetamine ...............................................................................................................................................
N,N-Dimethylamphetamine ......................................................................................................................................
Aminorex .................................................................................................................................................................
4-Methylaminorex (cis isomer) ................................................................................................................................
Gamma Hydroxybutyric Acid ...................................................................................................................................
Methaqualone ..........................................................................................................................................................
Mecloqualone ..........................................................................................................................................................
JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole) ...........................................................................................
VerDate Sep<11>2014
18:07 Mar 26, 2018
Jkt 244001
PO 00000
Frm 00023
Fmt 4703
Sfmt 4703
E:\FR\FM\27MRN1.SGM
27MRN1
1233
1235
1237
1238
1246
1248
1249
1258
1475
1480
1585
1590
2010
2565
2572
6250
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
13142
Federal Register / Vol. 83, No. 59 / Tuesday, March 27, 2018 / Notices
amozie on DSK30RV082PROD with NOTICES
Controlled substance
Drug code
SR-18 (Also known as RCS–8) (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl) indole) ........................................
5-Fluoro-UR-144 and XLR11 [1-(5-Fluoro-pentyl)1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone .........
AB-FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) ..............
JWH–019 (1-Hexyl-3-(1-naphthoyl)indole) ..............................................................................................................
AB-PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) ..................................
THJ-2201 [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone ............................................................
AB-CHMINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide .........
MAB-CHMINACA (N-(1-amino-3,3dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide)
ADB-PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) ..........................
APINACA and AKB48 N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide ......................................................
JWH-081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) indole) ...........................................................................................
SR-19 (Also known as RCS–4) (1-Pentyl-3-[(4-methoxy)-benzoyl] indole .............................................................
JWH018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) ........................................................................
JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl) indole) ..............................................................................................
UR-144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone ..........................................................
JWH-073 (1-Butyl-3-(1-naphthoyl)indole) ................................................................................................................
JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole) ...................................................................................
AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) indole) ...............................................................................................
JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl) indole) ..............................................................................................
PB-22 (Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate) ..........................................................................................
5F-PB-22 (Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate) ......................................................................
Alpha-ethyltryptamine ..............................................................................................................................................
CP-47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol) .........................................................
CP-47,497 C8 Homologue (5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol) ...................................
Lysergic acid diethylamide ......................................................................................................................................
2,5-Dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) ........................................................................................
Tetrahydrocannabinols ............................................................................................................................................
Mescaline ................................................................................................................................................................
2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine (2C-T-2 ) ....................................................................................
3,4,5-Trimethoxyamphetamine ................................................................................................................................
4-Bromo-2,5-dimethoxyamphetamine .....................................................................................................................
4-Bromo-2,5-dimethoxyphenethylamine ..................................................................................................................
4-Methyl-2,5-dimethoxyamphetamine .....................................................................................................................
2,5-Dimethoxyamphetamine ....................................................................................................................................
JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl) indole) ..............................................................................................
2,5-Dimethoxy-4-ethylamphetamine ........................................................................................................................
3,4-Methylenedioxyamphetamine ............................................................................................................................
5-Methoxy-3,4-methylenedioxyamphetamine ..........................................................................................................
N-Hydroxy-3,4-methylenedioxyamphetamine ..........................................................................................................
3,4-Methylenedioxy-N-ethylamphetamine ...............................................................................................................
3,4-Methylenedioxymethamphetamine ....................................................................................................................
4-Methoxyamphetamine ..........................................................................................................................................
5-Methoxy-N–N-dimethyltryptamine ........................................................................................................................
Alpha-methyltryptamine ...........................................................................................................................................
Bufotenine ...............................................................................................................................................................
Diethyltryptamine .....................................................................................................................................................
Dimethyltryptamine ..................................................................................................................................................
Psilocybin ................................................................................................................................................................
Psilocyn ...................................................................................................................................................................
N-Ethyl-1-phenylcyclohexylamine ............................................................................................................................
1-(1-Phenylcyclohexyl)pyrrolidine ............................................................................................................................
1-[1-(2-Thienyl)cyclohexyl]piperidine .......................................................................................................................
1-[1-(2-Thienyl)cyclohexyl]pyrrolidine ......................................................................................................................
N-Ethyl-3-piperidyl benzilate ....................................................................................................................................
N-Methyl-3-piperidyl benzilate .................................................................................................................................
N-Benzylpiperazine .................................................................................................................................................
4-Methyl-alphapyrrolidinopropiophenone (4-MePPP) .............................................................................................
2-(2,5-Dimethoxy-4-methylphenyl) ethanamine (2C-D) ..........................................................................................
2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine (2C-E ) ............................................................................................
2-(2,5-Dimethoxyphenyl) ethanamine (2C-H) .........................................................................................................
2-(4-iodo-2,5-dimethoxyphenyl) ethanamine (2C-I) ................................................................................................
2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine (2C-C) ...........................................................................................
2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine (2C-N) .............................................................................................
2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine (2C-P) ......................................................................................
2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine (2C-T-4) .............................................................................
MDPV (3,4-Methylenedioxypyrovalerone) ...............................................................................................................
2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25B-NBOMe) .............................................
2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25C-NBOMe) .............................................
2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25I-NBOMe) ..................................................
Methylone (3,4-Methylenedioxy-N-methylcathinone) ..............................................................................................
Butylone ...................................................................................................................................................................
Pentylone .................................................................................................................................................................
alpha-pyrrolidinopentiophenone (a-PVP) ................................................................................................................
alpha-pyrrolidinobutiophenone (a-PBP) ..................................................................................................................
VerDate Sep<11>2014
18:07 Mar 26, 2018
Jkt 244001
PO 00000
Frm 00024
Fmt 4703
Sfmt 4703
E:\FR\FM\27MRN1.SGM
27MRN1
7008
7011
7012
7019
7023
7024
7031
7032
7035
7048
7081
7104
7118
7122
7144
7173
7200
7201
7203
7222
7225
7249
7297
7298
7315
7348
7370
7381
7385
7390
7391
7392
7395
7396
7398
7399
7400
7401
7402
7404
7405
7411
7431
7432
7433
7434
7435
7437
7438
7455
7458
7470
7473
7482
7484
7493
7498
7508
7509
7517
7518
7519
7521
7524
7532
7535
7536
7537
7538
7540
7541
7542
7545
7546
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
13143
Federal Register / Vol. 83, No. 59 / Tuesday, March 27, 2018 / Notices
Controlled substance
Drug code
amozie on DSK30RV082PROD with NOTICES
AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) indole) ............................................................................................
Heroin ......................................................................................................................................................................
Normorphine ............................................................................................................................................................
U-47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide) .......................................................
AH-7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide)) ..........................................................
Alphacetylmethadol except levo-alphacetylmethadol ..............................................................................................
Alphameprodine ......................................................................................................................................................
Alphamethadol .........................................................................................................................................................
Benzethidine ............................................................................................................................................................
Betacetylmethadol ...................................................................................................................................................
Clonitazene ..............................................................................................................................................................
Diampromide ...........................................................................................................................................................
Diethylthiambutene ..................................................................................................................................................
Dimethylthiambutene ...............................................................................................................................................
1-Methyl-4-phenyl-4-propionoxypiperidine ..............................................................................................................
1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine ......................................................................................................
Tilidine .....................................................................................................................................................................
Para-Fluorofentanyl .................................................................................................................................................
3-Methylfentanyl ......................................................................................................................................................
Alpha-methylfentanyl ...............................................................................................................................................
Acetyl-alpha-methylfentanyl .....................................................................................................................................
Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) .......................................................................
Beta-hydroxyfentanyl ...............................................................................................................................................
Beta-hydroxy-3-methylfentanyl ................................................................................................................................
Alpha-methylthiofentanyl .........................................................................................................................................
3-Methylthiofentanyl ................................................................................................................................................
Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide) .....................................................
Thiofentanyl .............................................................................................................................................................
Tetrahydrofuranyl fentanyl .......................................................................................................................................
Cyclopropyl Fentanyl ...............................................................................................................................................
Fentanyl-related Substance ....................................................................................................................................
Amphetamine ..........................................................................................................................................................
Methamphetamine ...................................................................................................................................................
1-Phenylcyclohexylamine ........................................................................................................................................
Phencyclidine ..........................................................................................................................................................
4-Anilino-N-phenethyl-4-piperidine (ANPP) .............................................................................................................
Phenylacetone .........................................................................................................................................................
1-Piperidinocyclohexanecarbonitrile ........................................................................................................................
Alphaprodine ...........................................................................................................................................................
Anileridine ................................................................................................................................................................
Cocaine ...................................................................................................................................................................
Diphenoxylate ..........................................................................................................................................................
Ecgonine ..................................................................................................................................................................
Levorphanol .............................................................................................................................................................
Meperidine ...............................................................................................................................................................
Meperidine intermediate-A ......................................................................................................................................
Meperidine intermediate-B ......................................................................................................................................
Meperidine intermediate-C ......................................................................................................................................
Dextropropoxyphene, bulk (non-dosage forms) ......................................................................................................
Morphine ..................................................................................................................................................................
Levo-alphacetylmethadol .........................................................................................................................................
Alfentanil ..................................................................................................................................................................
Remifentanil .............................................................................................................................................................
Sufentanil .................................................................................................................................................................
Carfentanil ...............................................................................................................................................................
Tapentadol ...............................................................................................................................................................
Fentanyl ...................................................................................................................................................................
The company plans to manufacture
the above-listed controlled substances
as analytical reference standards for
distribution to its customers. In
reference to drug code 7370
tetrahydrocannabinols the company
plans to bulk manufacture as synthetic
substances. No other activity for this
drug code is authorized for this
registration.
VerDate Sep<11>2014
18:07 Mar 26, 2018
Jkt 244001
7694
9200
9313
9547
9551
9603
9604
9605
9606
9607
9612
9615
9616
9619
9661
9663
9750
9812
9813
9814
9815
9821
9830
9831
9832
9833
9834
9835
9843
9845
9850
1100
1105
7460
7471
8333
8501
8603
9010
9020
9041
9170
9180
9220
9230
9232
9233
9234
9273
9300
9648
9737
9739
9740
9743
9780
9801
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
Dated: March 15, 2018.
Susan A. Gibson,
Deputy Assistant Administrator.
DEPARTMENT OF JUSTICE
[FR Doc. 2018–06090 Filed 3–26–18; 8:45 am]
Christopher D. Owens, M.D.: Decision
and Order
BILLING CODE 4410–09–P
PO 00000
Drug Enforcement Administration
On August 11, 2017, the Acting
Assistant Administrator, Diversion
Control Division, Drug Enforcement
Administration, issued an Order to
Show Cause to Christopher D. Owens,
M.D. (hereinafter, Registrant), of San
Frm 00025
Fmt 4703
Sfmt 4703
E:\FR\FM\27MRN1.SGM
27MRN1
]]>Agencies
[Federal Register Volume 83, Number 59 (Tuesday, March 27, 2018)]
[Notices]
[Pages 13141-13143]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-06090]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Bulk Manufacturer of Controlled Substances Application: Synthcon,
LLC
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration in accordance with 21 CFR
1301.33(a) on or before May 29, 2018.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DRW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The Attorney General has delegated his
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to exercise all necessary functions with respect to the promulgation
and implementation of 21 CFR part 1301, incident to the registration of
manufacturers, distributors, dispensers, importers, and exporters of
controlled substances (other than final orders in connection with
suspension, denial, or revocation of registration) has been redelegated
to the Deputy Assistant Administrator of the DEA Office of Diversion
Control (``Deputy Assistant Administrator'') pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR 1301.33(a), this is notice that on
January 29, 2018, Synthcon, LLC, 770 Wooten Road, Unit 101, Colorado
Springs, CO 80915 applied to be registered as a bulk manufacturer of
the following basic classes of controlled substances:
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
3-Fluoro-N-methylcathinone (3- 1233 I
FMC).
Cathinone....................... 1235 I
Methcathinone................... 1237 I
4-Fluoro-N-methylcathinone (4- 1238 I
FMC).
Pentedrone ([alpha]- 1246 I
methylaminovalerophenone).
Mephedrone (4-Methyl-N- 1248 I
methylcathinone).
4-Methyl-N-ethylcathinone (4- 1249 I
MEC).
Naphyrone....................... 1258 I
N-Ethylamphetamine.............. 1475 I
N,N-Dimethylamphetamine......... 1480 I
Aminorex........................ 1585 I
4-Methylaminorex (cis isomer)... 1590 I
Gamma Hydroxybutyric Acid....... 2010 I
Methaqualone.................... 2565 I
Mecloqualone.................... 2572 I
JWH-250 (1-Pentyl-3-(2- 6250 I
methoxyphenylacetyl) indole).
[[Page 13142]]
SR-18 (Also known as RCS-8) (1- 7008 I
Cyclohexylethyl-3-(2-
methoxyphenylacetyl) indole).
5-Fluoro-UR-144 and XLR11 [1-(5- 7011 I
Fluoro-pentyl)1H-indol-3-
yl](2,2,3,3-
tetramethylcyclopropyl)methanon
e.
AB-FUBINACA (N-(1-amino-3-methyl- 7012 I
1-oxobutan-2-yl)-1-(4-
fluorobenzyl)-1H-indazole-3-
carboxamide).
JWH-019 (1-Hexyl-3-(1- 7019 I
naphthoyl)indole).
AB-PINACA (N-(1-amino-3-methyl-1- 7023 I
oxobutan-2-yl)-1-pentyl-1H-
indazole-3-carboxamide).
THJ-2201 [1-(5-fluoropentyl)-1H- 7024 I
indazol-3-yl](naphthalen-1-
yl)methanone.
AB-CHMINACA (N-(1-amino-3-methyl- 7031 I
1-oxobutan-2-yl)-1-
(cyclohexylmethyl)-1H-indazole-
3-carboxamide.
MAB-CHMINACA (N-(1-amino- 7032 I
3,3dimethyl-1-oxobutan-2-yl)-1-
(cyclohexylmethyl)-1H-indazole-
3-carboxamide).
ADB-PINACA (N-(1-amino-3,3- 7035 I
dimethyl-1-oxobutan-2-yl)-1-
pentyl-1H-indazole-3-
carboxamide).
APINACA and AKB48 N-(1- 7048 I
Adamantyl)-1-pentyl-1H-indazole-
3-carboxamide.
JWH-081 (1-Pentyl-3-(1-(4- 7081 I
methoxynaphthoyl) indole).
SR-19 (Also known as RCS-4) (1- 7104 I
Pentyl-3-[(4-methoxy)-benzoyl]
indole.
JWH018 (also known as AM678) (1- 7118 I
Pentyl-3-(1-naphthoyl)indole).
JWH-122 (1-Pentyl-3-(4-methyl-1- 7122 I
naphthoyl) indole).
UR-144 (1-Pentyl-1H-indol-3- 7144 I
yl)(2,2,3,3-
tetramethylcyclopropyl)methanon
e.
JWH-073 (1-Butyl-3-(1- 7173 I
naphthoyl)indole).
JWH-200 (1-[2-(4- 7200 I
Morpholinyl)ethyl]-3-(1-
naphthoyl)indole).
AM2201 (1-(5-Fluoropentyl)-3-(1- 7201 I
naphthoyl) indole).
JWH-203 (1-Pentyl-3-(2- 7203 I
chlorophenylacetyl) indole).
PB-22 (Quinolin-8-yl 1-pentyl-1H- 7222 I
indole-3-carboxylate).
5F-PB-22 (Quinolin-8-yl 1-(5- 7225 I
fluoropentyl)-1H-indole-3-
carboxylate).
Alpha-ethyltryptamine........... 7249 I
CP-47,497 (5-(1,1- 7297 I
Dimethylheptyl)-2-[(1R,3S)-3-
hydroxycyclohexyl-phenol).
CP-47,497 C8 Homologue (5-(1,1- 7298 I
Dimethyloctyl)-2-[(1R,3S)3-
hydroxycyclohexyl-phenol).
Lysergic acid diethylamide...... 7315 I
2,5-Dimethoxy-4-(n)- 7348 I
propylthiophenethylamine (2C-T-
7).
Tetrahydrocannabinols........... 7370 I
Mescaline....................... 7381 I
2-(4-Ethylthio-2,5- 7385 I
dimethoxyphenyl) ethanamine (2C-
T-2 ).
3,4,5-Trimethoxyamphetamine..... 7390 I
4-Bromo-2,5-dimethoxyamphetamine 7391 I
4-Bromo-2,5- 7392 I
dimethoxyphenethylamine.
4-Methyl-2,5- 7395 I
dimethoxyamphetamine.
2,5-Dimethoxyamphetamine........ 7396 I
JWH-398 (1-Pentyl-3-(4-chloro-1- 7398 I
naphthoyl) indole).
2,5-Dimethoxy-4-ethylamphetamine 7399 I
3,4-Methylenedioxyamphetamine... 7400 I
5-Methoxy-3,4- 7401 I
methylenedioxyamphetamine.
N-Hydroxy-3,4- 7402 I
methylenedioxyamphetamine.
3,4-Methylenedioxy-N- 7404 I
ethylamphetamine.
3,4- 7405 I
Methylenedioxymethamphetamine.
4-Methoxyamphetamine............ 7411 I
5-Methoxy-N-N-dimethyltryptamine 7431 I
Alpha-methyltryptamine.......... 7432 I
Bufotenine...................... 7433 I
Diethyltryptamine............... 7434 I
Dimethyltryptamine.............. 7435 I
Psilocybin...................... 7437 I
Psilocyn........................ 7438 I
N-Ethyl-1-phenylcyclohexylamine. 7455 I
1-(1- 7458 I
Phenylcyclohexyl)pyrrolidine.
1-[1-(2- 7470 I
Thienyl)cyclohexyl]piperidine.
1-[1-(2- 7473 I
Thienyl)cyclohexyl]pyrrolidine.
N-Ethyl-3-piperidyl benzilate... 7482 I
N-Methyl-3-piperidyl benzilate.. 7484 I
N-Benzylpiperazine.............. 7493 I
4-Methyl- 7498 I
alphapyrrolidinopropiophenone
(4-MePPP).
2-(2,5-Dimethoxy-4-methylphenyl) 7508 I
ethanamine (2C-D).
2-(2,5-Dimethoxy-4-ethylphenyl) 7509 I
ethanamine (2C-E ).
2-(2,5-Dimethoxyphenyl) 7517 I
ethanamine (2C-H).
2-(4-iodo-2,5-dimethoxyphenyl) 7518 I
ethanamine (2C-I).
2-(4-Chloro-2,5-dimethoxyphenyl) 7519 I
ethanamine (2C-C).
2-(2,5-Dimethoxy-4-nitro-phenyl) 7521 I
ethanamine (2C-N).
2-(2,5-Dimethoxy-4-(n)- 7524 I
propylphenyl) ethanamine (2C-P).
2-(4-Isopropylthio)-2,5- 7532 I
dimethoxyphenyl) ethanamine (2C-
T-4).
MDPV (3,4- 7535 I
Methylenedioxypyrovalerone).
2-(4-bromo-2,5-dimethoxyphenyl)- 7536 I
N-(2-methoxybenzyl) ethanamine
(25B-NBOMe).
2-(4-chloro-2,5-dimethoxyphenyl)- 7537 I
N-(2-methoxybenzyl) ethanamine
(25C-NBOMe).
2-(4-iodo-2,5-dimethoxyphenyl)-N- 7538 I
(2-methoxybenzyl) ethanamine
(25I-NBOMe).
Methylone (3,4-Methylenedioxy-N- 7540 I
methylcathinone).
Butylone........................ 7541 I
Pentylone....................... 7542 I
alpha-pyrrolidinopentiophenone 7545 I
([alpha]-PVP).
alpha-pyrrolidinobutiophenone 7546 I
([alpha]-PBP).
[[Page 13143]]
AM-694 (1-(5-Fluoropentyl)-3-(2- 7694 I
iodobenzoyl) indole).
Heroin.......................... 9200 I
Normorphine..................... 9313 I
U-47700 (3,4-dichloro-N-[2- 9547 I
(dimethylamino)cyclohexyl]-N-
methylbenzamide).
AH-7921 (3,4-dichloro-N-[(1- 9551 I
dimethylamino)cyclohexylmethyl]
benzamide)).
Alphacetylmethadol except levo- 9603 I
alphacetylmethadol.
Alphameprodine.................. 9604 I
Alphamethadol................... 9605 I
Benzethidine.................... 9606 I
Betacetylmethadol............... 9607 I
Clonitazene..................... 9612 I
Diampromide..................... 9615 I
Diethylthiambutene.............. 9616 I
Dimethylthiambutene............. 9619 I
1-Methyl-4-phenyl-4- 9661 I
propionoxypiperidine.
1-(2-Phenylethyl)-4-phenyl-4- 9663 I
acetoxypiperidine.
Tilidine........................ 9750 I
Para-Fluorofentanyl............. 9812 I
3-Methylfentanyl................ 9813 I
Alpha-methylfentanyl............ 9814 I
Acetyl-alpha-methylfentanyl..... 9815 I
Acetyl Fentanyl (N-(1- 9821 I
phenethylpiperidin-4-yl)-N-
phenylacetamide).
Beta-hydroxyfentanyl............ 9830 I
Beta-hydroxy-3-methylfentanyl... 9831 I
Alpha-methylthiofentanyl........ 9832 I
3-Methylthiofentanyl............ 9833 I
Furanyl fentanyl (N-(1- 9834 I
phenethylpiperidin-4-yl)-N-
phenylfuran-2-carboxamide).
Thiofentanyl.................... 9835 I
Tetrahydrofuranyl fentanyl...... 9843 I
Cyclopropyl Fentanyl............ 9845 I
Fentanyl-related Substance...... 9850 I
Amphetamine..................... 1100 II
Methamphetamine................. 1105 II
1-Phenylcyclohexylamine......... 7460 II
Phencyclidine................... 7471 II
4-Anilino-N-phenethyl-4- 8333 II
piperidine (ANPP).
Phenylacetone................... 8501 II
1- 8603 II
Piperidinocyclohexanecarbonitri
le.
Alphaprodine.................... 9010 II
Anileridine..................... 9020 II
Cocaine......................... 9041 II
Diphenoxylate................... 9170 II
Ecgonine........................ 9180 II
Levorphanol..................... 9220 II
Meperidine...................... 9230 II
Meperidine intermediate-A....... 9232 II
Meperidine intermediate-B....... 9233 II
Meperidine intermediate-C....... 9234 II
Dextropropoxyphene, bulk (non- 9273 II
dosage forms).
Morphine........................ 9300 II
Levo-alphacetylmethadol......... 9648 II
Alfentanil...................... 9737 II
Remifentanil.................... 9739 II
Sufentanil...................... 9740 II
Carfentanil..................... 9743 II
Tapentadol...................... 9780 II
Fentanyl........................ 9801 II
------------------------------------------------------------------------
The company plans to manufacture the above-listed controlled
substances as analytical reference standards for distribution to its
customers. In reference to drug code 7370 tetrahydrocannabinols the
company plans to bulk manufacture as synthetic substances. No other
activity for this drug code is authorized for this registration.
Dated: March 15, 2018.
Susan A. Gibson,
Deputy Assistant Administrator.
[FR Doc. 2018-06090 Filed 3-26-18; 8:45 am]
BILLING CODE 4410-09-P
